期刊
JOURNAL OF MATERIALS SCIENCE
卷 56, 期 12, 页码 7386-7396出版社
SPRINGER
DOI: 10.1007/s10853-020-05647-7
关键词
-
资金
- National Natural Science Foundation of China [21601124, 21671135, 21701111]
- Shanghai Sailing Programme [17YF1413700]
- Ministry of Education of China [PCSIRT_IRT_16R49]
- International Joint Laboratory on Resource Chemistry (IJLRC)
This study successfully constructed the efficient T-1 MRI contrast agent Gd-DTPA@ZIF-8, which has good longitudinal relaxivity and biocompatibility, showing significantly enhanced imaging effects in in vivo MRI experiments.
Gd-chelate magnetic resonance imaging (MRI) contrast agents used in conventional clinical medicine still have some shortcomings, such as their low relaxation rates and poor imaging sensitivity. In this work, a Gd-chelate (Gd-DTPA), with a comparison made to the commercial contrast agent Magnevist was loaded into a zeolitic imidazolate framework (ZIF-8) to construct the efficient T-1 MRI contrast agent Gd-DTPA@ZIF-8. At 0.5 T, the longitudinal relaxivity value (r(1)) of Gd-DTPA@ZIF-8 reaches 29.60 mM(-1) s(-1), which is about 6 times higher than that of Gd-DTPA. In terms of the retention of Gd-DTPA in ZIF-8, no obvious Gd3+ ions are released in water and complete culture solution over a long time period. Haemolysis and cytotoxicity experiments revealed that Gd-DTPA@ZIF-8 has good biocompatibility. In addition, the in vivo MRI results prove that Gd-DTPA@ZIF-8 can significantly enhance the T-1-weighted MRI contrast effect of the tumour site. These advantages make Gd-DTPA@ZIF-8 a potential candidate for biomedical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据